G2G CONSULTING

Lobbying for SHEPHERD THERAPEUTICS · rare cancer R&D

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · posted Apr 16, 2026

Lobbying activity 2

Defense

regarding funding and awareness of rare cancers

Veterans

regarding funding and awareness of rare cancers

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem